Ypsomed has a total of 2162 patents globally, out of which 1029 have been granted. Of these 2162 patents, more than 32% patents are active. The United States of America is where Ypsomed has filed the maximum number of patents, followed by Europe and Germany. Parallelly, Germany seems to be the main focused R&D center and also Switzerland is the origin country of Ypsomed Holding.
Ypsomed was founded in 2003. Ypsomed operates as a holding company. The Company, through its subsidiaries, develops and manufactures custom-made injection systems for pharmaceutical and bio-technology companies. As of September 2022, Ypsomed has a market cap of $2 Billion.
Do read about some of the most popular patents of Ypsomed which have been covered by us in this article and also you can find Ypsomed patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Ypsomed patent portfolio.
How many patents does the Founder and CEO of Ypsomed have?
The Founder Willy Michel has 18 patents and the CEO Simon Michel have 29 patents.
How many patents does Ypsomed have?
Ypsomed has a total of 2162 patents globally. These patents belong to 482 unique patent families. Out of 2162 patents, 708 patents are active.
How Many Patents did Ypsomed File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||Ypsomed Applications Filed||Ypsomed Patents Granted|
How many Ypsomed patents are Alive/Dead?
How Many Patents did Ypsomed File in Different Countries?
Countries in which Ypsomed Filed Patents
|United States Of America||381|
|Hong Kong (S.A.R.)||9|
Where are Research Centers of Ypsomed Patents Located?
10 Best Ypsomed Patents
US7056302B2 is the most popular patent in the Ypsomed portfolio. It has received 610 citations so far from companies like Abbott, Unomedica and Dexcom, Inc.
Below is the list of 10 most cited patents of Ypsomed Holding:
|Publication Number||Citation Count|
Which Companies are using Ypsomed Patents to Advance their Research?
If patents or patents from a particular technology area of a company receive a lot of citations, it implies that the technology is being followed and incrementally innovated by the citing companies. It also indicates that citing companies are working on similar and closely related technologies.
The top citing companies in the Ypsomed patent portfolio are Sanofi, Becton Dickinson and Shl Medical.
List of the top forward citing Companies –
|Company||Number of Patents|
|Shl Medical Ag||27|
|Novo Nordisk As||22|
|Medtronic Minimed Inc||11|
|Norton Healthcare Limited||8|
|Tecpharma Licensing Ag||8|
Count of 102 and 103 Type Rejections based on Ypsomed Patents
Top Ypsomed Patents used in Rejecting Most Patent Applications
|Patent Number||Count of Rejected Applications|
What Percentage of Ypsomed US Patent Applications were Granted?
Ypsomed (Excluding its subsidiaries) has filed 177 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 132 have been granted leading to a grant rate of 98.5%.
Below are the key stats of Ypsomed patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Ypsomed Holding?
|Law Firm||Total Applications||Success Rate|
|Dorsey & Whitney Llp||157||98.23%|
|Knobbe Martens Olson & Bear Llp||15||100.00%|
|David E Bruhn Esq||3||100.00%|
|Hamre Schumann Mueller & Larson Pc||1||100.00%|
|T Gene Dillahunty||1||100.00%|